Chemoinformaics analysis of BENZYL BETA-D-GLUCOPYRANOSIDE
| Molecular Weight | 270.281 | nRot | 4 |
| Heavy Atom Molecular Weight | 252.137 | nRig | 12 |
| Exact Molecular Weight | 270.11 | nRing | 2 |
| Solubility: LogS | -0.657 | nHRing | 1 |
| Solubility: LogP | -0.462 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 37 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 19 | No. of Aromatic Carbocycles | 1 |
| nHetero | 6 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 13 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 6 | No. of Arom Bond | 6 |
| nHA | 6 | APOL | 38.5243 |
| nHD | 4 | BPOL | 21.5297 |
| QED | 0.56 |
| Synth | 3.176 |
| Natural Product Likeliness | 1.615 |
| NR-PPAR-gamma | 0.004 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.01 |
| HIA | 0.89 |
| CACO-2 | -5.255 |
| MDCK | 0.00092958 |
| BBB | 0.529 |
| PPB | 0.20029 |
| VDSS | 0.663 |
| FU | 0.65486 |
| CYP1A2-inh | 0.016 |
| CYP1A2-sub | 0.054 |
| CYP2c19-inh | 0.013 |
| CYP2c19-sub | 0.083 |
| CYP2c9-inh | 0.001 |
| CYP2c9-sub | 0.085 |
| CYP2d6-inh | 0.003 |
| CYP2d6-sub | 0.203 |
| CYP3a4-inh | 0.002 |
| CYP3a4-sub | 0.057 |
| CL | 1.534 |
| T12 | 0.525 |
| hERG | 0.047 |
| Ames | 0.409 |
| ROA | 0.061 |
| SkinSen | 0.055 |
| Carcinogencity | 0.047 |
| EI | 0.025 |
| Respiratory | 0.02 |
| NR-Aromatase | 0.009 |
| Antiviral | Yes |
| Prediction | 0.810592 |